TWi Biotechnology, Inc. (6610.TWO)
TWD 9.83
(2.72%)
TWD 9.83
(2.72%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -143.86 Million TWD | 8.87% |
| 2022 | -157.87 Million TWD | 14.11% |
| 2021 | -183.81 Million TWD | -224.58% |
| 2020 | -56.63 Million TWD | 1.27% |
| 2019 | -57.36 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -194.01 Million TWD | 1.35% |
| 2024 Q1 | -194.01 Million TWD | -34.86% |
| 2023 Q1 | -122.41 Million TWD | 22.46% |
| 2023 Q2 | -121.14 Million TWD | 1.04% |
| 2023 FY | -143.86 Million TWD | 8.87% |
| 2023 Q4 | -143.86 Million TWD | 1.62% |
| 2023 Q3 | -146.23 Million TWD | -20.7% |
| 2022 Q3 | -160.4 Million TWD | 0.0% |
| 2022 Q4 | -157.87 Million TWD | 1.58% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 45.541% |
| Level Biotechnology Inc. | -453.9 Million TWD | 68.305% |
| Sagittarius Life Science Corp | -120.57 Million TWD | -19.319% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | 26.749% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 128.781% |
| GlycoNex Incorporation | -148.56 Million TWD | 3.166% |
| VBI | -25.31 Million TWD | -468.269% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 457.282% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 204.252% |
| Visgeneer Inc. | 31.28 Million TWD | 559.861% |
| Mycenax Biotech Inc. | 207 Million TWD | 169.496% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 78.863% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | -7.159% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 123.146% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -149.511% |
| Enimmune corporation | -314.15 Million TWD | 54.207% |
| TaiRx, Inc. | -147.86 Million TWD | 2.709% |
| CHO Pharma, Inc. | -203.79 Million TWD | 29.407% |
| EirGenix Inc. | -4.58 Billion TWD | 96.864% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | -69.724% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 219.022% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 95.53% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 54.677% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | -626.104% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 552.271% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 383.446% |
| RBC Bioscience Corporation | 422.18 Million TWD | 134.076% |
| BiOptic Inc. | 12.59 Million TWD | 1242.495% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 84.767% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | -41.756% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 12.903% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 145.689% |
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -86.728% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 45.212% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 570.479% |
| Neith Corporation | -150.31 Million TWD | 4.29% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -123.664% |
| NaviFUS Corp. | -123.12 Million TWD | -16.839% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 294.276% |
| Sinew Pharma Inc. | -160.34 Million TWD | 10.279% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 40.526% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 57.358% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 65.136% |
| AP Biosciences Inc | -196.52 Million TWD | 26.798% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 120.888% |
| 3D Global Biotech Inc. | -11.43 Million TWD | -1157.874% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 82.661% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 110.599% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 65.324% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 31.277% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 56.477% |
| TCI GENE Inc. | -689.25 Million TWD | 79.128% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | -20.956% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 89.011% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 802.353% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | -41.222% |
| PharmaEngine, Inc. | -860.8 Million TWD | 83.287% |
| Savior Lifetec Corporation | -812.54 Million TWD | 82.295% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 52.041% |
| OBI Pharma, Inc. | -398.22 Million TWD | 63.874% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 60.631% |
| Acepodia, Inc. | -6.02 Billion TWD | 97.61% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 95.771% |